Hypertriglyceridemia
📧 Sign up to get email alerts when something new happens for Hypertriglyceridemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-03-03Clinical Trial Update: Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients [Phase 4]
Phase 4 trial evaluating Extraneal (icodextrin) and triglyceride levels in peritoneal dialysis patients was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-09-16Clinical Trial Update: Safety and Efficacy of MAT9001(Omega-3-pentaenoic Acid) in Subjects With Triglycerides ≥500 mg/dL and <2000 mg/dL [Phase 3]
Phase 3 trial of MAT9001 (Omega-3-pentaenoic Acid) in severe hypertriglyceridemia was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-11-25Clinical Trial Update: The Efficacy of EPA+DHA (SC401B) for Lowering Triglyceride Levels (≥ 500 mg/dL) [Phase 3]
A Phase 3 trial of EPA+DHA (SC401B) for lowering triglycerides in severe hypertriglyceridemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-09-01Clinical Trial Update: Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides [Phase 3]
Phase 3 trial of Diazoxide Choline Controlled-Release Tablet (DCCR) for hypertriglyceridemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-09-01Clinical Trial Update: Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline [Phase 1]
The clinical trial NCT00901823, an open-label Phase 1 pharmacokinetic study of diazoxide choline for hypertriglyceridemia, has been withdraw…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-02-08Clinical Trial Update: Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in Hypertriglyceridemia [Phase 4]
A Phase 4 trial assessing Lovaza's impact on HDL composition and function in hypertriglyceridemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-03-22Clinical Trial Update: Garlic in Hyperlipidemia Caused by HAART [Phase 2]
This update indicates a Phase 2 trial evaluating garlic for HAART-induced hyperlipidemia in people with HIV has been withdrawn.